[1]
S. KAPICIOĞLU et al. 2020. Effect of Somatostatin Analogue (SMS 201-995) Administration on Portal Blood Flow in Patients with Liver Cirrhosis. Turkish Journal of Gastroenterology. 3, 3 (Apr. 2020), 469–473.